Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roundup Safety Data Relied on by EPA is Flawed and Outdated, Scientists Says August 21, 2015 Irvin Jackson Add Your Comments Two prominent doctors are calling for federal regulators to review the safety of Roundup and other glyphosate-based herbicides, indicating that new information about the potential risks to human health make the data previously relied on by the U.S. Environmental Protection Agency (EPA) outdated. The EPA has previously given glyphosate a clean bill of health in the past, but the doctors indicate that the agency relied on flawed Roundup safety data. In an editorial in the New England Journal of Medicine on August 26, the two doctors, Philip J. Landrigan and Charles Benbrook, raised questions about the overall safety of genetically modified organisms (GMOs) and crops, and called for a new assessment of Roundup and glyphosate. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In March, the International Agency for Research on Cancer (IARC), an arm of the World Health Organization (WHO), announced that it had determined that the herbicide glyphosate probably causes cancer in humans. The designation has raised questions about the safety of the world’s most popular weed killer, Monsanto’s Roundup, and outraged the agricultural industry giant. The EPA announced in April that it plans to address the safety concerns of glyphosate during the regular EPA safety review hearing at some point in the near future. Monsanto has said that the IARC’s conclusions were agenda-driven and based on “junk science,” and has said it is convening its own independent panel to review the cancer risks of Roundup, which is the most widely used weed killer in the world. Landrigan, the Dean for Global Health at Mount Sinai Medical Center in New York and a leading pediatrician, and Benbrook, who works as an adjunct professor in the crops and soil science department at Washington State University, warn that glyphosate is overused in the U.S. and there is mounting evidence that it is unsafe. What’s more, they say that Monsanto’s creation of herbicide-resistant crops, then marketed as “Roundup Ready” has made the U.S. overly reliant on their products. “These ‘Roundup-Ready’ crops now account for more than 90% of the corn and soybeans planted in the United States. Their advantage, especially in the first years after introduction, is that they greatly simplify weed management,” the doctors noted. “But widespread adoption of herbicide-resistant crops has led to overreliance on herbicides and, in particular, glyphosate.” The doctors note that glyphosate use in the U.S. has increased by a factor of more than 350, from 0.4 million kilograms (kg) to 113 million kg from 1974 to 2014. Global use has increased tenfold. “[T]he National Toxicology Program should urgently assess the toxicology of pure glyphosate, formulated glyphosate, and mixtures of glyphosate and other herbicides,” they wrote. Of particular concern to the doctors was last year’s EPA approval of Enlist Duo, a new formulation of glyphosate which includes the chemical 2,4-D, which was a component in the Agent Orange defoliant used during the Vietnam War which has sense been linked to a number of illnesses that affected veterans of that conflict. The doctors called the science behind the EPA’s approval flawed and noted that 2, 4-D is listed as a possible human carcinogen, and now glyphosate is considered a probable human carcinogen, raising serious questions about the safety of Enlist Duo. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Glyphosate, GMOs, Monsanto, Roundup Image Credit: Photo Courtesy of <a href="https://www.flickr.com/photos/jeepersmedia/14873964648/in/photolist-oEmXum-oEn9ki-oWRbVK-oEmWnm-oWzFRi-oWPp5q-oEmvVY-oEmahn-oEmb2Z-r4HEKx-qrgbpD-qr3Syo-qrgb6x-r4HT7B-qrg5px-r6sNDC-rnWUhU-rnV1kP-qr3DSm-rnWEWf-qrfS4a-qk19Pd-argEhZ-7xtMSn-ettS6G-qk2CQb-qnhf96-pqi9cy-8CVPxp-pqwwpc-smqxZX-sjb3fb-7xtMYM-q5QsjF-rinfWJ-qndT8S-pqwisv-pqhREq-qndxjo-qn6XWT-q5Hp19-q5JaP9-q5J8Wm-q5HsUG-qngP1k-qn6VRF-fj2VwZ-cnzyy9-seffn5-rV4Khp">Mike Mozart via Flickr</a> Creative Commons More Roundup Lawsuit Stories Roundup Safety Study Retracted Decades After Publication December 8, 2025 Monsanto Roundup Settlement Avoids $2B Payout in Non-Hodgkin’s Lymphoma Lawsuit November 18, 2025 Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Paraquat Lawsuits Over Parkinson’s Disease Continue To Be Filed, As MDL Stay Extended (Posted: 2 days ago) Syngenta and Chevron continue to face a growing number of Paraquat lawsuits as the parties attempt to finalize a settlement agreement. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Parkinson’s Disease Settlement Payout Amounts Still Being Finalized (10/03/2025)Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized (08/12/2025)Pesticide Exposure Could Lead to Higher Rheumatoid Arthritis Risks for Women Farm Workers: Study (07/23/2025) Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: 4 days ago) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025) Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: 5 days ago) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Paraquat Lawsuits Over Parkinson’s Disease Continue To Be Filed, As MDL Stay Extended (Posted: 2 days ago) Syngenta and Chevron continue to face a growing number of Paraquat lawsuits as the parties attempt to finalize a settlement agreement. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Parkinson’s Disease Settlement Payout Amounts Still Being Finalized (10/03/2025)Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized (08/12/2025)Pesticide Exposure Could Lead to Higher Rheumatoid Arthritis Risks for Women Farm Workers: Study (07/23/2025)
Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: 4 days ago) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: 5 days ago) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)